Zenas BioPharma, Inc. (NASDAQ:ZBIO) filed a Form 8-K with the Securities and Exchange Commission on February 13, 2026, disclosing a material event.
Zenas BioPharma, Inc.'s stock currently trades at $26.40 with a market capitalization of $1.7B. The Healthcare company's stock moved following the disclosure.